tiprankstipranks
Advertisement
Advertisement

EDIT Stock Latest News

Editas Medicine appoints Dan Ory as chief medical officer
The FlyEditas Medicine appoints Dan Ory as chief medical officer
5d ago
EDIT
Editas Medicine files $400M mixed securities shelf
PremiumThe Fly
Editas Medicine files $400M mixed securities shelf
13d ago
EDIT
Editas Medicine initiated with a Buy at Ladenburg
PremiumThe Fly
Editas Medicine initiated with a Buy at Ladenburg
26d ago
EDIT
Phil Nadeau Reiterates Buy on Editas Medicine, Citing Strong Cash Runway and Upcoming EDIT-401 Clinical Catalyst
PremiumRatings
Phil Nadeau Reiterates Buy on Editas Medicine, Citing Strong Cash Runway and Upcoming EDIT-401 Clinical Catalyst
1M ago
EDIT
Editas Medicine Strengthens Board With New Cardiology Director
PremiumCompany Announcements
Editas Medicine Strengthens Board With New Cardiology Director
1M ago
8K
EDIT
Editas Medicine reports Q2 EPS (15c), consensus (28c)
PremiumThe FlyEditas Medicine reports Q2 EPS (15c), consensus (28c)
1M ago
EDIT
EDIT Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
EDIT Earnings this Week: How Will it Perform?
1M ago
EDIT
Editas Medicine Shareholders Back Board, Pay and Auditor
Premium
Company Announcements
Editas Medicine Shareholders Back Board, Pay and Auditor
3M ago
8K
EDIT
Private Markets: Bezos’ Prometheus raises $12B as OpenAI files for IPO
PremiumThe Fly
Private Markets: Bezos’ Prometheus raises $12B as OpenAI files for IPO
3M ago
GS
TP
Editas Medicine preclinical data ‘looks highly supportive,’ says Evercore ISI
PremiumThe Fly
Editas Medicine preclinical data ‘looks highly supportive,’ says Evercore ISI
4M ago
EDIT
TD Cowen remains bullish on Editas Medicine after ‘compelling preclinical data’
PremiumThe Fly
TD Cowen remains bullish on Editas Medicine after ‘compelling preclinical data’
4M ago
EDIT
Editas Medicine Raises Capital Through Public Equity Offering
PremiumCompany Announcements
Editas Medicine Raises Capital Through Public Equity Offering
4M ago
8K
EDIT
Editas Medicine 55.6M share Secondary priced at $2.25
PremiumThe FlyEditas Medicine 55.6M share Secondary priced at $2.25
4M ago
EDIT
Editas Medicine Suspends Existing At-The-Market Offering Prospectus
Premium
Company Announcements
Editas Medicine Suspends Existing At-The-Market Offering Prospectus
4M ago
8K
EDIT
Editas Medicine announces common stock, warrant offering, no amount given
Premium
The Fly
Editas Medicine announces common stock, warrant offering, no amount given
4M ago
EDIT
Editas Showcases Promising EDIT-401 Data for Hyperlipidemia
PremiumCompany Announcements
Editas Showcases Promising EDIT-401 Data for Hyperlipidemia
4M ago
8K
EDIT
Analyst Maintains Buy on Editas Medicine, Reiterates $5 Price Target on EDIT-401 Progress and Strong Cash Runway
PremiumRatings
Analyst Maintains Buy on Editas Medicine, Reiterates $5 Price Target on EDIT-401 Progress and Strong Cash Runway
4M ago
EDIT
Editas Medicine presented preclinical data for EDIT-401 at EAS Congress
PremiumThe Fly
Editas Medicine presented preclinical data for EDIT-401 at EAS Congress
4M ago
EDIT
Editas Showcases Promising EDIT-401 Hyperlipidemia Preclinical Data
PremiumCompany Announcements
Editas Showcases Promising EDIT-401 Hyperlipidemia Preclinical Data
4M ago
8K
EDIT
Editas Medicine’s EDIT-401 shows efficacy and safety in hyperlipidemia
PremiumThe FlyEditas Medicine’s EDIT-401 shows efficacy and safety in hyperlipidemia
4M ago
EDIT
FDA Commissioner Marty Makary resigns
Premium
The Fly
FDA Commissioner Marty Makary resigns
4M ago
AZN
BMY
Analyst Phil Nadeau Reiterates Buy on Editas Medicine, Citing Promising EDIT-401 Data, Strong Cash Runway, and Large Untapped HeFH Opportunity
Premium
Ratings
Analyst Phil Nadeau Reiterates Buy on Editas Medicine, Citing Promising EDIT-401 Data, Strong Cash Runway, and Large Untapped HeFH Opportunity
4M ago
EDIT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >